Skip to main content

Table 1 Overview of patient population

From: Impact of beam configuration on VMAT plan quality for Pinnacle3Auto-Planning for head and neck cases

Case

Disease type

Treatment concept

Fractionation Scheme Dose D95 in Gy

Fractions

Side location

1

SCC, Hypopharynx

Primary RCT

59,4/66/69,3

33

bilateral

2

SCC, Oral cavity

Adjuvant RT

54/66

30

bilateral

3

SCC, Oropharynx

Adjuvant RT

54/66

30

bilateral

4

SCC, Oral cavity

Adjuvant RCT

54/66

30

bilateral

5

SCC, Oropharynx

Adjuvant RCT

60/66

30

bilateral

6

SCC, Oral cavity

Adjuvant RCT

54/66

30

bilateral

7

SCC, Oropharynx

Adjuvant RCT

54/66

30

bilateral

8

SCC, Oral cavity

Adjuvant RCT

54/66

30

bilateral

9

CUP, Oropharynx

Adjuvant RT

52,7/65,1

31

bilateral

10

SCC, Oral cavity

Adjuvant RCT

54/66

30

bilateral

11

SCC, Oropharynx

Adjuvant RT

54/66

30

unilateral

12

SCC, Oropharynx

Adjuvant RCT

54/66

30

unilateral

13

SCC, Oropharynx

Adjuvant RCT

60/66

30

unilateral

14

Undifferentiated orbital cancer

Adjuvant RT

60/66

30

unilateral

15

SCC, external auditory canal

Adjuvant RT

54/66

30

unilateral

16

SCC, occipital skin

Adjuvant RT

54/66

30

unilateral

17

SCC, Oropharynx

Adjuvant RCT

54/66

30

unilateral

18

SCC, Nasal cavity

Adjuvant RT

54/66

30

unilateral

19

SCC, Oral cavity

Adjuvant RCT

60/66

30

unilateral

20

NHL of the parotid gland

Adjuvant RT

40

20

unilateral

  1. All except one patient (Case #20) were treated with a simultaneously integrated boost technique with 2–3 dose levels
  2. CUP Cancer of Unknown Primacy, RCT Radio-Chemo Therapy, RT Radiotherapy, SCC Squamous Cell Carcinoma
  3. Disease type, treatment concept, fractionation scheme and tumor side location are described for all 20 patients